The FDA also announced plans for a subsequent advisory review that will include Melanotan II among additional peptide-related substances
While these medications show promise for muting the physiological urge to binge, they are not suitable for everyone
This price erosion is expected to democratize access, moving treatments from a luxury for the affluent to a viable option for a broader population
TGFR, transforming growth factor receptor
Consider contacting your GP if: Hair loss is significant, rapid, or causing distress You have noticed other new symptoms alongside hair loss for example, fatigue, weight changes, or cold intolerance (which may suggest a thyroid problem), or nail changes and eyebrow or eyelash loss Hair loss began within weeks to months of starting a new medication You have a personal or family history of autoimmune conditions You notice scalp pain, burning, redness, scaling, pustules, or any signs of scarring these may indicate a more serious condition requiring prompt assessment A child develops patchy hair loss with scaling or broken hairs, which may suggest tinea capitis (a fungal scalp infection) Your GP may recommend blood tests to check thyroid function, full blood count, ferritin, and other relevant markers, in line with NICE CKS guidance on alopecia assessment
This can be discussed further in detail with your provider
